Lawson Research Institute

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1983-01-01

Employees: -

Market Cap: -

Website: http://www.lawsonresearch.ca

Clinical Trials

IOP Device Comparison Study

Completed

Conditions: Intraocular Pressure

Interventions: Device: Icare Tonometer

First Posted Date: 2019-12-26

Last Posted Date: 2021-09-02

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 101

Registration Number: NCT04211792

Locations: 🇨🇦
Ivey Eye Institute at St Joseph hospital, London, Ontario, Canada

Validation of a High-Quality Low-Cost Open-Source Electrocardiograph

Not Applicable

Conditions: Electrocardiograph
Open Access
Medical Devices
Low Cost

Interventions: Device: Medical device validation

First Posted Date: 2019-12-23

Last Posted Date: 2022-08-25

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 450

Registration Number: NCT04209062

Locations: 🇨🇦
London Health Sciences Centre, London, Ontario, Canada

Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer

Phase 2

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Radiation: Hypofractionated WPRT
Radiation: Conventionally-fractionated WPRT

First Posted Date: 2019-12-12

Last Posted Date: 2023-08-18

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 58

Registration Number: NCT04197141

Locations: 🇨🇦
BC Cancer, Kelowna, British Columbia, Canada
🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦
London Regional Cancer Program of the Lawson Health Research Institute, London, Ontario, Canada

Kidney Sodium Content in Cardiorenal Patients

Not Applicable

Recruiting

Conditions: Cardio-Renal Syndrome

Interventions: Drug: Furosemide Injection

First Posted Date: 2019-11-20

Last Posted Date: 2024-01-29

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 50

Registration Number: NCT04170855

Locations: 🇨🇦
Heart Failure Clinic | St. Joseph's Health Care London, London, Ontario, Canada

Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota Transplantation

Phase 1

Active, not recruiting

Conditions: Renal Cell Carcinoma

Interventions: Drug: Fecal Microbiota Transplantation

First Posted Date: 2019-11-14

Last Posted Date: 2023-12-19

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 20

Registration Number: NCT04163289

Locations: 🇨🇦
London Regional Cancer Program of the Lawson Health Research Institute, London, Ontario, Canada

FMT for MS Patients

Phase 2

Not yet recruiting

Conditions: Multiple Sclerosis

Interventions: Biological: Fecal Microbial Transplants

First Posted Date: 2019-11-04

Last Posted Date: 2022-10-25

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 34

Registration Number: NCT04150549

Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients with CRS

Phase 4

Active, not recruiting

Conditions: Chronic Rhinosinusitis with Nasal Polyps
Aspirin-exacerbated Respiratory Disease

Interventions: Drug: Placebo
Drug: Celecoxib

First Posted Date: 2019-10-31

Last Posted Date: 2024-10-29

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 44

Registration Number: NCT04147013

Locations: 🇨🇦
St. Joseph's Healthcare London, London, Ontario, Canada
🇸🇦
King Abdulaziz University Hospital, Jeddah, Saudi Arabia

Cryoablation of the Retrograde Fast Pathway as Treatment for AVNRT

Early Phase 1

Conditions: Atrioventricular Node Arrhythmia

Interventions: Procedure: Cardiac catheter ablation

First Posted Date: 2019-10-10

Last Posted Date: 2019-11-20

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 20

Registration Number: NCT04122807

Locations: 🇨🇦
Lawson Health Research Institute, London, Ontario, Canada

Continuous Renal Replacement Therapy for Acute Kidney Injury by Cooling Blood

Phase 2

Withdrawn

Conditions: Acute Kidney Injury
Continuous Renal Replacement Therapy

Interventions: Procedure: Dialysis cooling

First Posted Date: 2019-09-25

Last Posted Date: 2024-03-13

Lead Sponsor: Lawson Health Research Institute

Registration Number: NCT04103307

Locations: 🇨🇦
Critical Care Trauma Centre, London, Ontario, Canada

Outcomes of a Higher vs. Lower Hemodialysate Magnesium Concentration (Dial-Mag Canada)

Not Applicable

Active, not recruiting

Conditions: Kidney Diseases
End-Stage Kidney Disease
Hemodialysis

Interventions: Other: Dialysate magnesium formulation of 1.5 mEq/L (0.75 mmol/L).
Other: Dialysate magnesium formulation of ≤1.0 mEq/L (≤0.5 mmol/L).

First Posted Date: 2019-09-06

Last Posted Date: 2024-03-13

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 25000

Registration Number: NCT04079582

Locations: 🇨🇦
London Health Sciences Centre, London, Ontario, Canada

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy